SPY458.97-10.47 -2.23%
DIA349.02-9.01 -2.52%
IXIC15,491.66-353.57 -2.23%

Alkermes Doses First Patient of Phase 1 Trial for Brain Disease Drug ALKS 1140

MT Newswires · 11/11/2021 02:55

Please log in to view news